Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma
NCT04911816
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Adenocarcinoma of the Pancreas
Interventions
DRUG:
Hydroxychloroquine sulfate
Sponsor
West Virginia University